Christian Elling
Managing Partner Lundbeckfonden BioCapital
Christian E. Elling heads the early stage biotech investment unit Lundbeckfonden BioCapital.
He is a member of the board of directors of IO Biotech, NMD Pharma, Afyx Therapeutics, SNIPR Biome, Folium and former member of the board of directors of EpiTherapeutics and Inagen.
Christian was previously co-founder, Vice President of Biology and Development and later CEO of 7TM Pharma. Christian received his early training in biochemistry and received his PhD in pharmacology from University of Copenhagen, Denmark.
